Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review.

ABSTRACT: Poor adherence to topical glaucoma medications has been linked to worse visual field outcomes in glaucoma patients. Therefore, identifying and overcoming the adherence barriers are expected to slow down the progression of disease. The most common barriers to adherence, in addition to the lack of knowledge, include forgetfulness, side effects of medications, difficulties with drop instillation and low self-efficacy. Symptoms and signs of ocular surface disease, which importantly reduce patients' quality of life, are decreased by using preservative-free topical medications. Sustained drug delivery systems using different vehicles seem promising for relieving the burden of drop administration. Currently, only the bimatoprost sustained-release intracameral implant is available for clinical use

SUBMITTER: Cvenkel B 

PROVIDER: S-EPMC9821329 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature